Purpose
We sought to develop a matrix assisted laser desorption ionization-time of flight (MALDI-TOF)-based, ovarian cancer (OVC), low-mass-ion discriminant equation (LOME) and to evaluate a possible supportive role for triple-TOF mass analysis in identifying metabolic biomarkers.
Materials and Methods
A total of 114 serum samples from patients with OVC and benign ovarian tumors were subjected to MALDI-TOF analysis and a total of 137 serum samples from healthy female individuals and patients with OVC, colorectal cancer, hepatobiliary cancer, and pancreatic cancer were subjected to triple-TOF analysis. An OVC LOME was constructed by reference to the peak intensity ratios of discriminatory low-mass ion (LMI) pairs. Triple-TOF analysiswas used to select and identify metabolic biomarkers for OVC screening.
Results
Three OVC LOMEs were finally constructed using discriminatory LMI pairs (137.1690 and 84.4119 m/z; 496.5022 and 709.7642 m/z; and 524.5614 and 709.7642 m/z); all afforded accuracies of > 90%. The LMIs at 496.5022 m/z and 524.5614 m/z were those of lysophosphatidylcholine (LPC) 16:0 and LPC 18:0. Triple-TOF analysis selected seven discriminative LMIs; each LMI had a specificity > 90%. Of the seven LMIs, fourwith a 137.0455 m/z ion atretention times of 2.04-3.14 minuteswere upregulated in sera from OVC patients; the ion was identified as that derived from hypoxanthine.
Conclusion
MALDI-TOF–based OVC LOMEs combined with triple-TOF–based OVC metabolic biomarkers allow reliable OVC screening; the techniques are mutually complementary both quantitatively and qualitatively.
Citations
Citations to this article as recorded by
Detection of Protein and Metabolites in Cancer Analyses by MALDI 2000–2025 Dorota Bartusik-Aebisher, Daniel Roshan Justin Raj, David Aebisher Cancers.2025; 17(21): 3524. CrossRef
Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment Andrea Jiménez-Franco, Juan Manuel Jiménez-Aguilar, Marta Canela-Capdevila, Raquel García-Pablo, Helena Castañé, Cristian Martínez-Navidad, Pablo Araguas, Bárbara Malavé, Rocío Benavides-Villarreal, Johana C. Acosta, Alina Iuliana Onoiu, Navita Somaiah, J Biomedicines.2024; 12(10): 2196. CrossRef
Circulating proteins as predictive and prognostic biomarkers in breast cancer Hugo Veyssière, Yannick Bidet, Frederique Penault-Llorca, Nina Radosevic-Robin, Xavier Durando Clinical Proteomics.2022;[Epub] CrossRef
Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research Laura Darie-Ion, Danielle Whitham, Madhuri Jayathirtha, Yashveen Rai, Anca-Narcisa Neagu, Costel C. Darie, Brînduşa Alina Petre Molecules.2022; 27(19): 6196. CrossRef
Methylglyoxal Adducts Levels in Blood Measured on Dried Spot by Portable Near-Infrared Spectroscopy Giuseppe Bonapace, Francesco Gentile, Nicola Coppedé, Maria Laura Coluccio, Virginia Garo, Marco Flavio Michele Vismara, Patrizio Candeloro, Giuseppe Donato, Natalia Malara Nanomaterials.2021; 11(9): 2432. CrossRef
Identification of New Peptide Biomarkers for Bacterial Bloodstream Infection Yating Ma, Xinyu Wen, Yi Kong, Chen Chen, Ming Yang, Shang He, Jianan Wang, Chengbin Wang PROTEOMICS – Clinical Applications.2020;[Epub] CrossRef
Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis Kexin Li, Yuqing Pei, Yue Wu, Yi Guo, Wei Cui Journal of Ovarian Research.2020;[Epub] CrossRef
Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine Ji Hye Im, Byong Chul Yoo, Jun Hwa Lee, Kyung-Hee Kim, Tae Hoon Kim, Kyue-Yim Lee, Jong Heon Kim, Jong Bae Park, Ji-Woong Kwon, Sang Hoon Shin, Heon Yoo, Ho-Shin Gwak EPMA Journal.2020; 11(3): 469. CrossRef
Exploring Serum Metabolic Markers for the Discrimination of Ccrcc From Renal Angiomyolipoma By Metabolomics Mingfeng Xiang, Feng Du, Jing Dai, Ling Chen, Ruijin Geng, Huiming Huang, Baogang Xie Biomarkers in Medicine.2020; 14(8): 675. CrossRef
Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path? Igor Govorov , Stanislav Sitkin , Tatyana Pervunina , Alexey Moskvin , Denis Baranenko , Eduard Komlichenko Current Medicinal Chemistry.2020; 27(22): 3611. CrossRef
Purpose Patients show variable responses to chemoradiotherapy (CRT), which is generally administered before surgery for locally advanced rectal cancer (LARC). The aim of this study was to identify molecular markers predictive of CRT responses by analysis of low-mass ions (LMIs) in serum of LARC patients. Materials and Methods LMIs (< 1,000 m/z) in serum obtained before CRT from 73 LARC (cT3-4) patients were profiled using matrix-assisted laser desorption/ionization mass spectrometry. LMIs with higher weighting factors in discriminating CRT responses were selected using principal components analysis and discriminant analysis. Selected LMIs were identified using the Human Metabolome Database. The concentrations of identified LMIs were determined by colorimetric enzyme assay, and compared according to post-CRT pathological stage (ypStage) or Dworak’s tumor regression grade (TRG). Results The nine highest-ranking LMIs were selected. Among them, two LMIs with 137.08 and 169.04 m/z were identified as hypoxanthine (HX) and phosphoenolpyruvic acid (PEP), respectively. Higher HX concentration was observed in patients with ypStage 0-1 compared to ypStage 2-4 (p=0.034) or ypStage 3-4 (p=0.030); a similar difference was observed between TRG 4-3 and TRG 1 (p=0.035). HX > 16.0 μM showed significant association with ypStage 0-1 or TRG 4-3 than ypStage 3-4 (p=0.009) or TRG 1 (p=0.024), respectively. In contrast, a significantly lower concentration of PEP was observed in TRG 4-3 compared with TRG 2-1 (p=0.012). Conclusion Findings of this study demonstrated that serum concentrations of HX and PEP, identified using LMI profiling, may be useful for predicting the CRT response of LARC patients before treatment.
Citations
Citations to this article as recorded by
A single urine test-based SERS–AI–BAM for on-site multiple cancer diagnosis and metabolite profiling Hyo Jeong Seo, Jun Young Kim, Vo Thi Nhat Linh, Boyou Heo, Jun-Young Yang, Rowoon Park, In Woong Han, Sung-Gyu Park, Min-Young Lee, Samjin Choi, Ho Sang Jung Chemical Engineering Journal.2026; 530: 173116. CrossRef
Pilot Study of Metabolomic Biomarkers Associated with Outcomes in Patients with Lung Cancer Undergoing Radiation Therapy Wei Meng, Rui Xu, Eric Miller, Xiaowei Sun, Jennifer Thurmond, Amy Webb, Joseph McElroy, Joshua Palmer, Dominic J. DiCostanzo, Shiqi Zhang, Hisashi Yamaguchi, Saikh Jaharul Haque, Jiangjiang Zhu, Arnab Chakravarti Journal of Proteome Research.2025; 24(4): 1662. CrossRef
Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer Rui Ran, Xiaocui Zhong, Yang Yang, Xianglan Tang, Manlin Shi, Xingwei Jiang, Anping Lin, Xiaoling Gan, Tinghe Yu, Lina Hu, Xiaojing Dong, Ting-Li Han Medical Oncology.2023;[Epub] CrossRef
Effect of heat and hypoxia stress on mitochondrion and energy metabolism in the gill of hard clam Zhi Hu, Li Xu, Hao Song, Jie Feng, Cong Zhou, Mei-Jie Yang, Pu Shi, Yong-Ren Li, Yong-Jun Guo, Hai-Zhou Li, Tao Zhang Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology.2023; 266: 109556. CrossRef
Phosphoenolpyruvate regulates the Th17 transcriptional program and inhibits autoimmunity Tsung-Yen Huang, Masato Hirota, Daiki Sasaki, Rajkumar Singh Kalra, Hsiao-Chiao Chien, Miho Tamai, Shukla Sarkar, Yang Mi, Mio Miyagi, Yu Seto, Hiroki Ishikawa Cell Reports.2023; 42(3): 112205. CrossRef
Increased ENT2 expression and its association with altered purine metabolism in cell lines derived from different stages of colorectal cancer Safaa Naes, Sharaniza Ab‑Rahim, Musalmah Mazlan, Nurul Azmir Amir Hashim, Amirah Abdul Rahman Experimental and Therapeutic Medicine.2023;[Epub] CrossRef
Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer Jiali Lv, Huixun Jia, Miao Mo, Jing Yuan, Zhenyu Wu, Shuai Zhang, Fan Zhe, Bingbing Gu, Bingbing Fan, Chunxia Li, Tao Zhang, Ji Zhu Metabolomics.2022;[Epub] CrossRef
Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer Yuhong Chen, Biao Yang, Mingyang Chen, Zhaojun Li, Zhengyin Liao Frontiers in Bioscience-Landmark.2022;[Epub] CrossRef
Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance Beatriz Soldevilla, Angeles López-López, Alberto Lens-Pardo, Carlos Carretero-Puche, Angeles Lopez-Gonzalvez, Anna La Salvia, Beatriz Gil-Calderon, Maria C. Riesco-Martinez, Paula Espinosa-Olarte, Jacinto Sarmentero, Beatriz Rubio-Cuesta, Raúl Rincón, Cor Cancers.2021; 13(11): 2634. CrossRef
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients Feng Zhao, Rui An, Liqian Wang, Jikang Shan, Xianjun Wang Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Label‐free diagnosis for colorectal cancer through coffee ring‐assisted surface‐enhanced Raman spectroscopy on blood serum Yan Hong, Yongqiang Li, Libin Huang, Wei He, Shouxu Wang, Chong Wang, Guoyun Zhou, Yuanming Chen, Xin Zhou, Yifeng Huang, Wen Huang, Tianxun Gong, Zongguang Zhou Journal of Biophotonics.2020;[Epub] CrossRef
Exploring Serum Metabolic Markers for the Discrimination of Ccrcc From Renal Angiomyolipoma By Metabolomics Mingfeng Xiang, Feng Du, Jing Dai, Ling Chen, Ruijin Geng, Huiming Huang, Baogang Xie Biomarkers in Medicine.2020; 14(8): 675. CrossRef
The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study Luigi Barberini, Antonio Noto, Claudia Fattuoni, Giannina Satta, Mariagrazia Zucca, Maria Giuseppina Cabras, Ester Mura, Pierluigi Cocco Molecules.2019; 24(13): 2367. CrossRef
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer Jun Hwa Lee, Yun Hwan Kim, Kyung-Hee Kim, Jae Youl Cho, Sang Myung Woo, Byong Chul Yoo, Seung Cheol Kim Cancer Research and Treatment.2018; 50(3): 883. CrossRef
Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer Huixun Jia, Xiaotao Shen, Yun Guan, Meimei Xu, Jia Tu, Miao Mo, Li Xie, Jing Yuan, Zhen Zhang, Sanjun Cai, Ji Zhu, ZhengJiang Zhu Radiotherapy and Oncology.2018; 128(3): 548. CrossRef
Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data Manish Chand, Deborah S Keller, Reza Mirnezami, Marc Bullock, Aneel Bhangu, Brendan Moran, Paris P Tekkis, Gina Brown, Alex Mirnezami, Mariana Berho World Journal of Gastrointestinal Oncology.2018; 10(7): 145. CrossRef
Non-operative management of rectal cancer: understanding tumor biology Iris H. Wei, Julio Garcia-Aguilar Minerva Chirurgica.2018;[Epub] CrossRef
Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review Byong Chul Yoo, Seung-Gu Yeo EPMA Journal.2017; 8(1): 61. CrossRef
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer Delphine Dayde, Ichidai Tanaka, Rekha Jain, Mei Tai, Ayumu Taguchi International Journal of Molecular Sciences.2017; 18(3): 573. CrossRef
Global and targeted serum metabolic profiling of colorectal cancer progression Yin Long, Beatriz Sanchez‐Espiridion, Moubin Lin, Lindsey White, Lopa Mishra, Gottumakkala S. Raju, Scott Kopetz, Cathy Eng, Michelle A. T. Hildebrandt, David W. Chang, Yuanqing Ye, Dong Liang, Xifeng Wu Cancer.2017; 123(20): 4066. CrossRef
Nuclear Magnetic Resonance-Based Metabolomics Approach to Evaluate the Prevention Effect of Camellia nitidissima Chi on Colitis-Associated Carcinogenesis Ming-Hui Li, Hong-Zhi Du, Gui-Ju Kong, Li-Bao Liu, Xin-Xin Li, Sen-Sen Lin, Ai-Qun Jia, Sheng-Tao Yuan, Li Sun, Jun-Song Wang Frontiers in Pharmacology.2017;[Epub] CrossRef
Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival Kyung-Hee Kim, Jungnam Joo, Boram Park, Sang-Jae Park, Woo Jin Lee, Sung-Sik Han, Tae Hyun Kim, Eun Kyung Hong, Sang Myung Woo, Byong Chul Yoo Oncotarget.2017; 8(68): 112598. CrossRef
Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine Iris Eke, Adeola Y. Makinde, Molykutty J. Aryankalayil, Mansoor M. Ahmed, C. Norman Coleman Cancer Letters.2016; 382(1): 118. CrossRef
Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer Kangsan Roh, Seung-Gu Yeo, Byong Chul Yoo, Kyung-Hee Kim, Sun Young Kim, Min-Jeong Kim Anti-Cancer Drugs.2016; 27(8): 787. CrossRef
Synthesis and deposition of a Tröger’s base polymer on the electrode surface for potentiometric detection of a neuroblastoma tumor marker metabolite T. V. Shishkanova, M. Havlík, M. Dendisová, P. Matějka, V. Král Chemical Communications.2016; 52(80): 11991. CrossRef
Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12 Jong Hoon Lee, Dae Yong Kim, Sung Hwan Kim, Hyeon Min Cho, Byoung Yong Shim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Jae Hwan Oh, Taek Keun Nam, Mee Sun Yoon, Jae Uk Jeong, Kyubo Kim, Eui Kyu Chie, Hong Seok Jang, Jae-Sung Kim, Jin Hee Kim, Bae Kwon Je Radiotherapy and Oncology.2015; 116(2): 202. CrossRef